2021 annual financial data
GT Biopharma 2021 Net margin
GT Biopharma 2021 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -57,515,000 USD and net income was -58,013,000 USD.
Operating cash flow was -15,606,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -57,515,000 USD
- Net income
- -58,013,000 USD
- Operating cash flow
- -15,606,000 USD